Acuren Corp. Files 8-K Under 'Other Events'

Ticker: TICAW · Form: 8-K · Filed: Apr 24, 2025 · CIK: 2032966

Acuren Corp 8-K Filing Summary
FieldDetail
CompanyAcuren Corp (TICAW)
Form Type8-K
Filed DateApr 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, 8-K

Related Tickers: ACRN

TL;DR

ACRN filed an 8-K, but it's just 'other events' - no juicy details yet.

AI Summary

Acuren Corp. filed an 8-K on April 24, 2025, reporting an event that occurred on April 23, 2025. The filing is categorized under 'Other Events' and does not specify any financial transactions or material changes.

Why It Matters

This filing indicates Acuren Corp. has made a regulatory submission, but the lack of specific details means its immediate impact on investors is unclear.

Risk Assessment

Risk Level: low — The filing is a routine 8-K under 'Other Events' with no disclosed material information, suggesting low immediate risk.

Key Players & Entities

  • ACUREN CORP (company) — Registrant
  • April 23, 2025 (date) — Date of earliest event reported
  • April 24, 2025 (date) — Filing Date
  • 14434 Medical Complex Drive, Suite 100 Tomball, Texas 77377 (address) — Principal executive offices

FAQ

What specific event is Acuren Corp. reporting under 'Other Events'?

The filing does not specify the nature of the 'Other Events' beyond the date it occurred (April 23, 2025).

When did Acuren Corp. file this 8-K report?

Acuren Corp. filed this 8-K report on April 24, 2025.

What is Acuren Corp.'s principal executive office address?

Acuren Corp.'s principal executive offices are located at 14434 Medical Complex Drive, Suite 100, Tomball, Texas 77377.

What is Acuren Corp.'s telephone number?

Acuren Corp.'s telephone number is (800) 218-7450.

What is the SEC file number for Acuren Corp.?

Acuren Corp.'s SEC file number is 001-42524.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 24, 2025 regarding ACUREN CORP (TICAW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.